Skip to main content

Obagi Medical Products, Inc. (NASDAQ:OMPI) Investor Investigation Over Buyout Bid By Valeant Pharmaceuticals International Announced

  • If you purchased shares of Obagi Medical Products, Inc. (NASDAQ:OMPI) prior to March 20, 2013, and currently hold any of those NASDAQ:OMPI shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

Mar. 20, 2013 (Shareholders Foundation) - An investigation on behalf of investors in Obagi Medical Products, Inc. (NASDAQ:OMPI) shares was announced concerning whether the offer by Valeant Pharmaceuticals International to acquire Obagi Medical Products, Inc. for $19.75 per NASDAQ:OMPI share and the takeover process are unfair to investors in Obagi Medical Products shares. The investig...



You must register (for free) or login to view the entire investigation.